Decreasing disparity in liver transplantation among white and Asian patients with hepatocellular carcinoma : California, 1998-2005.
BACKGROUND
A preliminary study using national cancer surveillance data from 1998 through 2002 suggested that there were significant differences between non-Hispanic whites ('whites') and Asian/Pacific Islanders (APIs) in the use of liver transplantation as a treatment for hepatocellular carcinoma (HCC).


METHODS
The objective of the current study was to examine whether differences in liver transplantation between whites and APIs with HCC were changing over time. By using a population-based, statewide cancer registry, data were obtained on all HCC cases diagnosed in California between 1998 and 2005, and the study was limited to white and API patients with nonmetastatic HCC who had tumors that measured < or = 5 cm in greatest dimension (n = 1728 patients).


RESULTS
From 1998 through 2003 (n = 1051 patients), the odds of undergoing liver transplantation were 2.56 times greater for white patients than for API patients (95% confidence interval [CI], 1.72-3.80 times higher), even after adjusting for age, sex, marital status, year of diagnosis, TNM stage, and tumor grade. In contrast, during 2004 and 2005 (n = 677 patients), there were no significant differences in the odds of undergoing liver transplantation. Between 2002 and 2004, changes in liver transplantation policy assigned priority points to patients with HCC (initially to stage I and II, then to stage II only). After the policy changes, API patients with HCC experienced a significant increase in stage II diagnoses, whereas white patients did not.


CONCLUSIONS
In California, there was a large and significant disparity in the rate of liver transplantation among white and API patients with HCC from 1998 through 2003 but not during 2004 and 2005. Changes in liver transplantation policy from 2002 through 2004 may have played a role in decreasing this difference.
Robbins
Anthony S
AS
California Cancer Registry, Public Health Institute, Sacramento, California, USA. anthony.robbins@cancer.org
Daily
Michael F
MF
Aoki
Christopher A
CA
Chen
Moon S
MS
Troppmann
Christoph
C
Perez
Richard V
RV
D001213:Asian; D006528:Carcinoma, Hepatocellular / Q000473:pathology / Q000601:surgery*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000473:pathology / Q000601:surgery*; D016031:Liver Transplantation / Q000208:ethnology*; D008297:Male; D008875:Middle Aged; D044468:Native Hawaiian or Pacific Islander; D044465:White People
Am J Gastroenterol. 2002 Nov;97(11):2886-95
12425564
World J Surg. 2007 Jun;31(6):1243-8
17440771
CA Cancer J Clin. 1998 Jan-Feb;48(1):31-48
9449932
Liver Transpl Surg. 1996 Nov;2(6):426-30
9346688
Cancer. 2005 Dec 15;104(12 Suppl):2895-902
16270313
Liver Transpl. 2000 Nov;6(6 Suppl 2):S16-22
11084080
N Engl J Med. 1996 Mar 14;334(11):693-9
8594428
Hepatology. 2007 Oct;46(4):1034-40
17654490
Hepatology. 2001 Jan;33(1):62-5
11124821
Best Pract Res Clin Gastroenterol. 2005 Feb;19(1):101-18
15757807
J Cancer Res Clin Oncol. 2004 Jul;130(7):417-22
15042359
J Vasc Interv Radiol. 2002 Sep;13(9 Pt 2):S205-10
12354838
Transplantation. 2000 Sep 15;70(5):780-3
11003357
Aliment Pharmacol Ther. 2007 Aug 1;26(3):383-91
17635373
Transplantation. 1998 Aug 27;66(4):500-6
9734495
Liver Transpl. 2004 Jan;10(1):36-41
14755775
CA Cancer J Clin. 2007 Jul-Aug;57(4):190-205
17626117
N Engl J Med. 1987 Feb 19;316(8):484-5
3543681
Hepatology. 2005 Nov;42(5):1208-36
16250051
Cancer. 2005 Dec 15;104(12 Suppl):2975-81
16247792
J Hepatol. 2003;39 Suppl 1:S50-8
14708678
Am J Transplant. 2003 Nov;3(11):1407-12
14525602